In many tumor cell types, ionizing radiation (IR) or DNA-damaging anticancer drugs enhance sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, which is of great clinical interest. We have investigated the molecular mechanism underlying the response to combined modality treatment in p53-mutant Jurkat T leukemic cells overexpressing Bcl-2. These cells are largely resistant to individual treatment with TRAIL or IR, but sensitive to combined treatment, in vitro as well as in vivo. We demonstrate that IR and DNA-damaging anticancer drugs enable TRAIL receptor-2 and CD95/Fas to bypass the mitochondrial pathway for effector caspase activation. This was validated by RNA interference for Bax and Bak and by overexpression of dominant-negative Caspase-9. Improved effector caspase activation was neither caused by altered expression of proapoptotic components nor by impaired activity of inhibitor of apoptosis proteins or nuclear factor-jB signaling. Rather, we found that pretreatment of cells with IR caused quantitative and qualitative changes in death receptor signaling. It strongly improved the capacity of ligand-bound receptors to recruit FADD and activate Caspase-8 and -10 in the death-inducing signaling complex, while c-FLIP L levels were unaffected.
Introduction
Ionizing radiation (IR) and many conventional anticancer chemotherapeutics induce DNA damage, which will trigger cell cycle arrest, but may also result in apoptosis, which proceeds principally via the mitochondrial pathway (Strasser et al., 1994) . In this pathway, the Bcl-2 family plays a pivotal role. BH3-only members of the family perceive the apoptotic signal and allow their relatives Bak and Bax to mediate permeabilization of the mitochondrial outer membrane (Danial and Korsmeyer, 2004) . Upon release from mitochondria into the cytoplasm, cytochrome c (Cyt c) binds to the scaffold protein Apaf-1, which allows recruitment and activation of the inducer Caspase-9. Additionally released Smac/DIABLO and Omi/HtrA2 promote caspase activation by displacing inhibitor of apoptosis proteins (IAPs). Collectively, these events result in effector caspase activation and consequent execution of the apoptotic program (Wang, 2001) . The mitochondrial apoptosis pathway can be blocked by inhibitory Bcl-2 family members, which sequester their proapoptotic relatives (Danial and Korsmeyer, 2004) . In hematopoietic cells, overexpression of inhibitory Bcl-2 family members not only predisposes for tumor development, but also conveys resistance to chemotherapy in vivo (Schmitt et al., 2000) .
To date, toxicity of the death receptor ligands tumor necrosis factor (TNF)a and CD95 ligand (L) has precluded their use for systemic therapy. Recombinant soluble TNF-related apoptosis-inducing ligand (TRAIL), however, induces apoptosis in a large proportion of long-term established tumor cell lines, but is not toxic to normal tissue (Ashkenazi et al., 1999; Walczak et al., 1999) . TRAIL monotherapy is currently in phase I clinical trials in cancer patients. TRAIL also shows promise for therapeutic effectiveness in combination with classical anticancer regimens. This potential lies in part in its mechanism of apoptosis induction. Death receptors, such as TRAIL receptor-(R)1 and -R2 (DR4 and DR5) and CD95 (Fas/APO-1) can activate effector caspases independently of the mitochondria, that is, via another pathway than IR and chemotherapeutics. Ligand-induced receptor clustering leads to recruitment of the adapter molecule Fas-associated protein with death domain (FADD), inducer Caspase-8 and/or -10 and c-FLIP molecules (Sprick et al., 2002; Peter and Krammer, 2003) . In the death-inducing signaling complex (DISC) thus formed at the receptor tail, Caspase-8/10 are activated. Upon self-processing by proteolysis, they are released into the cytosol where they find effector caspases as their targets. This is the direct pathway for effector caspase activation. In addition, by cleaving and activating BH3-only protein Bid, Caspase-8/10 connect death receptors to the mitochondrial pathway (Luo et al., 1998) .
It depends on the cell type whether death receptors require the mitochondrial pathway for apoptotic execution. This has been ascertained by monitoring the effect of Bcl-2 overexpression or Bid deficiency on apoptosis induction, in particular by CD95. In this way, cells have been classified as type I or type II (Scaffidi et al., 1998; Barnhart et al., 2003) . In type II cells, the mitochondrial pathway is required for apoptosis induction, whereas in type I cells it is not. Type I and type II cells are discernible by the kinetics and effectiveness of DISC formation. It is proposed therefore that, in type II cells, the mitochondrial loop is required to amplify effector caspase activation (Scaffidi et al., 1998; Barnhart et al., 2003) . Death receptors can also activate the nuclear factor-kB (NF-kB) signaling pathway (Varfolomeev et al., 2005) , which can lead to transcriptional upregulation of apoptosis antagonists, such as inhibitory Bcl-2 family members, IAPs and c-FLIP (Aggarwal, 2004) .
In many studies with human tumor cell lines, TRAIL has additive or even synergistic interactions with anticancer drugs or IR in cell death induction. This has been shown both in vitro and upon xenografting of tumor cells in mice (Chinnaiyan et al., 2000; Belka et al., 2001 ). For certain cell lines, combined effects became more apparent when TRAIL was added 12-24 h after irradiation or chemotherapy (Singh et al., 2003; Marini et al., 2005) , which indicates that DNA-damaging regimens condition cells to more effectively undergo TRAIL-induced apoptosis. Since DNA damage primarily relies on the mitochondrial pathway for caspase activation, while death receptors can bypass mitochondria, it can be envisioned how combined treatment can have additive effects on the apoptotic response. In addition, DNA damage can transcriptionally upregulate TRAIL-R1, TRAIL-R2 (Wu et al., 1997; Guan et al., 2001) and CD95 (Mu¨ller et al., 1998) and stimulate CD95 transport to the cell surface (Bennett et al., 1998) , which may explain synergistic combined effects. However, combined effects are also observed without death receptor upregulation at the cell surface (Kim et al., 2001; Lacour et al., 2003; Vivo et al., 2003; Ganten et al., 2004) .
We have demonstrated that IR and TRAIL synergize for apoptosis induction in Jurkat T leukemic cells overexpressing Bcl-2. This translated in a strong combined therapeutic effect in vivo (Wissink et al., 2006) . In the present study, we have investigated the mechanism underlying the enhanced response to combined treatment. We find that Jurkat cells, which are type II and largely reliant on a mitochondrial contribution in apoptosis induction by death ligands (Scaffidi et al., 1998) , no longer require this pathway for apoptotic execution after irradiation (or treatment with DNA-damaging anti-cancer drugs). This is explained by a strong increase in the efficacy of FADD recruitment and Caspase-8 and -10 activation in the TRAIL DISC after irradiation.
Results
Combining DNA-damaging regimens with death receptor stimulation overcomes apoptosis resistance imposed by Bcl-2 In the Jurkat clone J16 transduced with Bcl-2 (J16-Bcl-2), the effects of IR and TRAIL on the apoptotic response are synergistic (Wissink et al., 2006) . To address the mechanism underlying this synergy, we examined whether it was also manifest for another DNA-damaging input, the topoisomerase II inhibitor etoposide, and for another death ligand, CD95L. Cells were stimulated with IR or etoposide, in combination with TRAIL or CD95L, in different doses. Apoptosis was read out by nuclear fragmentation 48 h later. Control J16 cells showed high levels of apoptosis upon individual treatments ( Figure 1a ). J16-Bcl-2 cells, on the other hand, showed low sensitivity to individual treatments, but high sensitivity to the combinations (Figure 1b) . These results indicate that distinct DNA-damaging anticancer regimens can sensitize J16 cells with a blockade in the mitochondrial pathway to apoptosis induction by TRAIL as well as CD95L.
Apoptosis induction upon combined treatment is independent of the mitochondrial pathway We have shown that combined treatment does not break Bcl-2-mediated mitochondrial resistance, as determined by Cyt c release (Wissink et al., 2006) . To corroborate this finding, we imposed an additional and independent blockade in the mitochondrial route by stable knock down (KD) of both Bak and Bax expression using RNA interference (RNAi). The effectiveness of the short hairpin constructs was demonstrated in J16 cells. Firstly, RNAi caused a significant reduction in steady-state Bak and Bax protein levels, as determined by immunoblotting ( Figure 2a , top left panel). Secondly, it significantly reduced the sensitivity of J16 cells to IR-induced apoptosis (Figure 2a , top right panel). Next, J16-Bcl-2 cells were transduced to coexpress the RNAi vectors for Bak and Bax. J16-Bcl-2 control cells and Bak/Bax KD cells were tested for sensitivity to single and combined modality treatment with IR and TRAIL in the indicated dose combinations (Figure 2a , bottom panels). The combined effect of IR and TRAIL on apoptosis induction appeared not to be dependent on a contribution by Bak and Bax, since it was not diminished in Bak/ Bax KD cells.
To inhibit the mitochondrial pathway at a control point that is not directly regulated by the Bcl-2 family, we tested apoptosis sensitivity of J16 cells expressing a dominant-negative (dn) mutant of Caspase-9 (J16-dnC9). The effectiveness of this mutant to block Caspase-9 activation was validated by subjecting J16 vector control cells and J16-dnC9 cells to IR. IR-induced apoptosis was strongly reduced upon stable expression of dnCaspase-9 (Figure 2b , top left panel). Next, sensitivity to combined treatment was tested, in this case in a presensitization set up. J16-dnC9 cells were irradiated or not and tested 15 h later for TRAILinduced Caspase-3 activation by flow cytometry, using a specific antibody. At t ¼ 0, 15 h after exposure to IR, no Caspase-3 activation had occurred. Subsequent treatment with TRAIL did induce Caspase-3 activation, and this was significantly increased at all time points in cells that had been irradiated as compared to nonirradiated cells (Figure 2b , top right panel). To allow for a quantitative comparison with the effect of IR on TRAIL-induced apoptosis in J16 control and J16-Bcl-2 cells, the ratio of active Caspase-3 in irradiated versus non-irradiated cells is shown for all three cell lines ( Figure 2b , bottom right panel). Primary data at t ¼ 4 h are given as illustration in the bottom left panel. The extent of sensitization was comparable for J16-Bcl-2 and J16-dnC9 cells. In J16 cells, the ratio returned to 1 at later time points, which can be explained by the fact that these cells can still activate the mitochondrial amplification loop. The collective results indicate that IR improves the capacity of TRAIL to induce apoptosis via the direct, mitochondrion-independent route.
IR improves the capacity of death receptors to activate effector caspases Next, we tested biochemically whether pretreatment of J16-Bcl-2 cells with IR facilitated TRAIL-induced Caspase-3 activation. J16-Bcl-2 cells were irradiated and 15 h later, treated with TRAIL. Caspase-3 processing and activity were monitored at various time points by immunoblotting. At 60 min after TRAIL stimulation, Caspase-3 processing was visible in irradiated cells, but not in control cells (Figure 3a ). Caspase-3 activity, as measured by cleavage of its substrate poly (ADP-ribose) polymerase (PARP), was also significantly enhanced in irradiated cells at this time point (Figure 3b ). Improved Caspase-3 activation and activity in irradiated cells was apparent throughout the kinetic analysis, which was performed up to 180 min after TRAIL stimulation. IR had similar effects on CD95L-induced Caspase-3 processing and activity (results not shown). We conclude that IR conditions the cells in such a way that the capacity of death receptors to activate effector caspases is improved.
Improved effector caspase activity is not due to decreased IAP function One scenario for improved effector caspase activation by death receptors in irradiated cells might be the altered Bottom panels: comparison of the extent of sensitization in J16 transduced with empty vector, dnCaspase-9 or Bcl-2. Cells were sensitized and stimulated as described above. Left panel: primary data at t ¼ 4 h. Right panel: ratio of active Caspase-3 in irradiated cells versus non-irradiated cells after TRAIL stimulation for the indicated periods of time. Apoptosis at t ¼ 0 (15 h after irradiation) was subtracted from all samples. Statistical differences (**Po0.01 and ***Po0.0001) between samples according to two-tailed Student's t-test. dnCaspase-9, dominant-negative Caspase-9; IR, ionizing radiation; KD, knock down; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand.
Smac is imported into mitochondria by virtue of this amino-terminal sequence and subsequently processed to the mature form, the D55 mutant is constitutively expressed in the cytoplasm (Du et al., 2000) . Cytoplasmic localization of DSmac was verified by immunoblotting of cytosolic and membrane fractions of J16-Bcl-2 cells. Whereas control J16-Bcl-2 cells only contained (endogenous) Smac in mitochondria, cells transduced with DSmac contained Smac in cytosol as well as mitochondria (Figure 4b) . Functionality of DSmac was tested by stimulating control and DSmac-transduced cells with TRAIL and assaying Caspase-3 activation at the indicated time points. In repeated experiments, there was limited, but significantly more Caspase-3 activation Ionizing radiation modulates the TRAIL DISC I Verbrugge et al ( Figure 4c ) and apoptosis induction (data not shown) in DSmac-transduced cells, indicating that the construct was functional. Next, DSmac-transduced cells were compared to control cells regarding their sensitivity to combined treatment with IR and TRAIL. IR sensitized both control and DSmac-expressing cells to a similar extent to TRAIL-induced apoptosis (Figure 4d) . We conclude that downregulation of IAP activity is not a likely explanation for the combined effects of IR and TRAIL on effector caspase activity.
IR improves the capacity of death receptors to activate Caspase-8 Caspase-3 and other effector caspases are directly activated by Caspase-8 in the mitochondrion-independent death receptor signaling pathway. Therefore, we investigated whether pretreatment with IR improved the capacity of J16-Bcl-2 cells to activate Caspase-8 upon TRAIL stimulation. For this purpose, Caspase-8 processing was followed in control and irradiated cells by immunoblotting of total cell lysates. As for Caspase-3 processing and activity (Figure 3 ), Caspase-8 processing was first observed at the 60 min time point in irradiated cells, but not in control cells (Figure 5a ). At each subsequent time point throughout a 180 min period, Caspase-8 processing was more pronounced in irradiated cells than in control cells (Figure 5a ).
To determine Caspase-8 activity, which can also be displayed by the full-length form (Boatright et al., 2003) , we blotted cell lysates for the short form of c-FLIP (c-FLIP S ), a highly specific Caspase-8 substrate (Peter and Krammer, 2003) . Processing of c-FLIP S was evident in irradiated, but not in control cells at the 60 min time point, when processed Caspase-8 and -3 were also first observed. Throughout the time course, c-FLIP S processing was more pronounced in irradiated than in control cells (Figure 5b) . We conclude that IR conditions J16-Bcl-2 cells for improved Caspase-8 activation by TRAIL. IR had similar effects on CD95L-induced Caspase-8 processing and activity (results not shown).
Modest effects of IR and etoposide on death receptor expression
Upregulation of death receptor expression at the plasma membrane was investigated, since it could potentially explain improved TRAIL-induced Caspase-3 activation in irradiated cells. At 15 h after treatment with the indicated doses IR or etoposide, plasma membrane levels of TRAIL-R1, TRAIL-R2 (Figure 6a ) and CD95 ( Figure 6b) were determined by flow cytometric analysis of J16-Bcl-2 cells. TRAIL-R1 was barely detectable, in accordance with published results (Sprick et al., 2002) and did not show any consistent upregulation after treatment. TRAIL-R2 levels were upregulated at most 1.5-fold upon IR or etoposide treatment and CD95 levels at most 1.3-fold. TRAIL decoy receptors were not detectable on J16-Bcl-2 cells either before or after IR (results not shown). Genome-wide mRNA expression profiling by microarray indicated that death-and decoy receptors were not transcriptionally regulated in 16 cells by IR or etoposide (Supplementary Figure 1) . We conclude that both stimuli have modest effects on receptor cell-surface expression.
IR improves the capacity of death receptors to form a DISC Caspase-8 is multimerized and activated at the death receptor tail, in the DISC, which consists of a death ligand, its cognate receptor(s), FADD, Caspase-8 and/ or -10, and c-FLIP molecules (Sprick et al., 2002; Peter and Krammer, 2003) . Therefore, we examined whether DISC formation was improved in irradiated cells as compared to control cells. The DISC was isolated from large numbers of J16-Bcl-2 cells by an established procedure (Sprick et al., 2002) , which involves stimulation with FLAG-tagged ligand and immunoprecipitation with anti-FLAG antibody. In this way, ligand, receptor and associated signaling components are isolated and can be immunoblotted to detect the individual components. J16-Bcl-2 cells were irradiated or left untreated. After 15 h, cells were stimulated with TRAIL for the indicated periods of time. Ionizing radiation modulates the TRAIL DISC I Verbrugge et al TRAIL-induced Caspase-3 (Figure 7a ) and PARP cleavage (data not shown), as ascertained by immunoblotting of total cell lysates, were clearly enhanced in irradiated cells. This result verified the synergy between IR and TRAIL in this setting.
There was a small increase in the amount of cellbound TRAIL visible at 1 h after TRAIL stimulation in irradiated versus non-irradiated cells (Figure 7b ). This is in agreement with the 1.5-fold increase in TRAIL-R2 membrane expression observed at this time point (Figure 6 ). However, from 2 h after TRAIL stimulation, a change in the stoichiometry of the DISC was apparent in irradiated cells. The FADD to TRAIL ratio in the DISC was about fourfold higher in irradiated versus non-irradiated cells (Figure 7b ). This result indicates that irradiation improves the capacity of TRAIL-R2 to recruit FADD, on a per receptor basis. The TRAIL DISC of irradiated cells also contained a larger amount of Caspase-8 and -10, as became apparent from 2 h after TRAIL stimulation (Figure 7b) . At later time points, the DISCs of irradiated cells clearly contained more processed Caspase-8 and -10. Interestingly, despite the increased levels of FADD, the amount of c-FLIP L in the TRAIL DISC was comparable between irradiated and control cells (Figure 7b) . Levels of c-FLIP isoforms in total cell lysates were not affected by IR (Figure 7c) , nor was c-FLIP mRNA expression (Supplementary Figure 1) . We conclude that in J16-Bcl-2 cells, IR affects the capacity of TRAIL-R2 to assemble a DISC in both quantitative and qualitative ways: FADD recruitment is enhanced and Caspase-8 and -10 content are favored over that of c-FLIP L . The apparent resultant is a more effective inducer of caspase activation.
Discussion
This work was initiated to explore the mechanism, which underlies combined effects between IR and TRAIL in apoptotic execution of J16-Bcl-2 cells. We conclude that IR conditions J16-Bcl-2 cells in such a way that TRAIL-bound receptors can more efficiently recruit FADD and activate inducer caspases in the DISC. This apparently translates into increased Caspase-8 activity in the cytosol and the capacity to bypass the mitochondrial pathway for effector caspase activation. Irradiated cells bound slightly more TRAIL than control cells (Figure 7) , proportional to the about 1.5-fold upregulation of TRAIL-R2 at the cell surface ( Figure 6 ). However, in irradiated cells four-to fivefold more FADD was recruited per TRAIL-ligated receptor complex than in control cells. This effect was thus standardized per activated receptor complex and cannot be explained by the availability of a higher number of TRAIL binding sites (receptors) at the cell surface. Since there might be threshold effect in FADD recruitment, we performed a direct test for a role of receptor upregulation in sensitization. We stably expressed exogenous TRAIL-R2 in J16-Bcl-2 cells by retroviral transduction of a pMX vector in a configuration encoding an internal ribosomal entry sequence (IRES) and green fluorescent protein (GFP). We observed a strong selection against high GFP (thus TRAIL-R2) expression and accomplished a 1.5-fold upregulation at the cell surface. Transduced cells did not display enhanced sensitivity to TRAIL alone as compared to control cells, and combined treatment with IR still gave supra-additive effects on the apoptotic response (data not shown). Together, with the qualitative changes seen in the DISC, the collective data argue that death receptor upregulation at the cell surface does not explain the increased sensitivity of J16-Bcl-2 cells to combined treatment.
Two other studies have documented that DNAdamaging stimuli-in this case chemotherapeutic drugs-improved TRAIL-induced DISC formation. This concerns HT-29 colon carcinoma cells, treated with cisplatin, doxorubicin or 5-fluorouracil (5-FU) (Lacour et al., 2003) and hepatocellular carcinoma, treated with 5-FU (Ganten et al., 2004) . These authors found, in common with our study, increased FADD and pro-Caspase-8/10, but not c-FLIP L content in the DISC, as well as increased Caspase-8/10 activity. 5-FU, but not the other drugs resulted in a decreased level of c-FLIP L in total cell lysates. In J16-Bcl-2 cells, we did not observe a decrease in total cellular c-FLIP L levels after irradiation. The collective findings indicate that DNA-damaging regimens condition cells in such a way that ligandbound death receptors become more competent to recruit FADD, but also assemble a qualitatively altered DISC. The DISC's capability to recruit FADD is increased, while its propensity to recruit and/or maintain c-FLIP L is not. The change in Caspase-8/10 versus c-FLIP L ratio may contribute to improved Caspase-8/10 activation.
The increased FADD recruitment and Caspase-8/10 activation in the DISC of irradiated cells may well explain the synergistic effects of IR and TRAIL. However, to gain evidence that this is the key mechanism underlying the combined effect, it was important to exclude other mechanisms. Altered IAP expression or function is unlikely according to our findings. Moreover, genome-wide mRNA expression profiling revealed that only three known apoptosis regulators are affected by both stimuli. BH3-only protein p53 upregulated modulator of apoptosis (PUMA) was modestly upregulated (Supplementary Figure 1) . However, in the combined treatment setting, PUMA cannot play a decisive role, since it acts in the mitochondrial pathway. In addition, we found upregulation of the inhibitor of NF-kB signaling a (IkBa), as well as the RelB component of the NF-kB complex ( Supplementary  Figure 1) . These two findings argue, respectively, in favor and against attenuated NF-kB signaling as explanation for the effect of DNA damaging regimens on TRAIL-induced apoptosis. We ruled out that attenuated NF-kB signaling plays a role in synergy by deliberate inhibition of the NF-kB pathway with a nonphosphorylatable mutant of IkBa (Supplementary Figure 2) .
We show here that combined treatment with IR and death receptor ligand allows bypass of the mitochondrial pathway for apoptotic execution in J16-Bcl-2 cells. In other cell types, however, the mitochondrial pathway was essential for the combined effect. Specifically, in DU145 prostate carcinoma and HCT-116 colon carcinoma, the combined effect of IR and TRAIL relied on Bax (Ravi and Bedi, 2002; Wendt et al., 2005) , in M28 mesothelioma it relied on Bid (Broaddus et al., 2005) and in a renal cell carcinoma it required Caspase-9 (Ramp et al., 2003) . Jurkat cells are classically defined as type II cells that require a mitochondrial contribution to After 15 h incubation, cells were stimulated with FLAG-TRAIL precoupled to biotinylated anti-FLAG antibody for the indicated periods of time. TRAIL-bound receptor complexes were isolated using streptavidin-conjugated sepharose beads. Synergy in this setting was confirmed by blotting corresponding cell lysates for Caspase-3 (a), where Actin served as a loading control. TRAIL, FADD, c-FLIP L , Caspase-8 and -10 (b) protein levels were detected by immunoblotting. DISC components were quantified from autoradiograms and normalized to corresponding TRAIL levels (arbitrary units). c-FLIP protein levels were determined in J16-Bcl-2 cells at 15 h after irradiation with 10 Gy (c). DISC, deathinducing signaling complex; IR, ionizing radiation; TRAIL, tumor necrosis factor-related apoptosis-inducing ligand.
Ionizing radiation modulates the TRAIL DISC I Verbrugge et al CD95L-induced apoptosis (Scaffidi et al., 1998) . However, as compared to type II solid tumor cell lines, Jurkat cells may be less reliant on this pathway. At high doses of death ligand and prolonged incubation, the direct pathway suffices for apoptotic execution (Belka et al., 2001; Rudner et al., 2005) . Possibly, therefore, improved inducer caspase activation by DNA-damaging stimuli is the common cause of the combined effects on apoptotic execution in all tumor cell types. In some tumor types, the mitochondrial pathway will still be required for apoptotic execution, while in other cell types, the direct pathway will suffice. Dose and activity of the recombinant TRAIL used and the consequent extent of inducer caspase activation might be a decisive factor in this.
Further work is needed to establish whether the here outlined quantitative and qualitative alterations in the DISC are a general principle by which DNA-damaging regimens increase cellular sensitivity to TRAIL-and CD95L-induced apoptosis. Regarding this mechanism, main outstanding questions are (1) how these cellular stressors couple back to the DISC and (2) what is the exact molecular basis of the altered capacity of death receptors to recruit DISC components. The JNK1 pathway is activated by diverse cellular stressors, including IR and anticancer drugs and has already been implicated in synergy between TRAIL and etoposide (Vivo et al., 2003) . Recent findings indicate that the JNK1 pathway controls c-FLIP L ubiquitination (Chang et al., 2006) , suggesting one answer to the first question. In addition, cellular stress may well impact on death receptor distribution in membrane microdomains (rafts) and/or endosomal compartments, which is a decisive factor for signaling outcome (Barnhart et al., 2003) . This is therefore an important area of further investigation.
Materials and methods

Cells and stimulation
The J16 Jurkat clone was derived and selected as described (Boesen-de Cock et al., 1999) . These cells have one wild-type and one mutant p53 allele and undergo DNA damage-induced apoptosis in a p53-independent manner (Werner et al., 2004; Wissink et al., 2006) . J16 cells, stably overexpressing Bcl-2 (J16-Bcl-2) or the dnCaspase-9 active site mutant C287A (J16-dnC9), were generated by retroviral transduction (Werner et al., 2004) . For apoptosis assays, J16 cells were stimulated with the indicated doses of death receptor ligand, etoposide or IR in Iscove's modified Dulbecco's medium with 5% fetal bovine serum and cultured for the indicated time periods at 371C, 5% CO 2 . Soluble human recombinant FLAG-tagged CD95L and -TRAIL were from Alexis (Lausen, Switzerland). Isoleucine zippered (IZ)-TRAIL was produced as described (Ganten et al., 2006 
Constructs
Unless stated otherwise, cDNAs were cloned into the retroviral vector pMX (Kitamura, 1998) in an IRES-GFP configuration. Plasmid pOTB7-DIABLO with a cDNA insert encoding full-length human Smac/DIABLO was from the Mammalian Gene Collection (http://mgc.nci.nih.gov). The D55 Smac mutant (Du et al., 2000) was produced by introducing suitable restriction sites by PCR. RNAi was performed using short hairpin RNA for Bak (complementary sense and antisense oligonucleotides 5 0 -GGACGACAT CAACCGACGC-3 0 ) and Bax (5 0 -CCAGCAAACTGGTGCT CAA-3 0 ) cloned into the retroviral vector pRETRO-SUPER (Brummelkamp et al., 2002) , with a hygromycin or puromycin resistance cassette, respectively. All constructs were verified by dideoxynucleotide sequencing.
Retroviral gene transduction
To produce retrovirus, pMX and pRETRO-SUPER constructs were transfected into the HT1080 packaging cell line FLY (Cosset et al., 1995) , using FuGENE 6 transfection reagent (Roche Molecular Biochemicals, Mannheim, Germany). After 48 h of culture, virus-containing supernatant was harvested. J16-Bcl-2 cells were seeded at 5 Â 10 5 cells/ml on dishes coated with RetroNectin (TaKaRa Bio USA, Madison WI, USA) and transduced by overnight culture in 500 ml viruscontaining supernatant plus 500 ml medium. Cells were cultured in fresh medium for 3-4 days after which GFPpositive cells were sorted by flow cytometry in case of transduction with pMX. Sorting was performed at least twice before starting experiments. Cells were selected after 3 days with 500 mg/ml hygromycin B (Invitrogen, Carlsbad, CA, USA) or 1 mg/ml puromycin (Sigma) in case of transduction with pRETRO-SUPER.
Apoptosis assays and flow cytometry Nuclear fragmentation was determined by flow cytometric analysis of propidium iodide (PI)-stained nuclei (Nicoletti et al., 1991) . Percentage of subdiploid PI-positive particles was scored as percentage apoptosis. Background apoptosis in medium control cells was always less than 10% and subtracted from the percentage apoptosis in stimulated cells. Active Caspase-3 content was determined by fixing the cells with 4% paraformaldehyde in phosphate-buffered saline (PBS) and permeabilizing them with 0.1% saponin in PBS and 0.5% bovine serum albumin. Cells were stained with rabbit antiactive Caspase-3 antibody (1:50; BD Biosciences, Erembodegem, Belgium) followed by AlexaFluor 647-conjugated goat anti-rabbit immunoglobulin (Ig) (1:100; Molecular Probes, Leiden, The Netherlands) and analysed by flow cytometry. For flow cytometric detection of death receptors, we used anti-CD95 mAb 7C11 (1:200; Immunotech, Marseille, France) combined with fluorescein isothiocyanate-conjugated goat anti-mouse Ig Fab 0 (1:200; Dako A/S, Glostrup, Denmark), or biotinylated anti-TRAIL-R1 mAb DJR1 and anti-TRAIL-R2 mAb DJR2-4 (1:250 and 1:500, eBioscience, San Diego, CA, USA) combined with streptavidin-allophycocyanin conjugate (1:200; Molecular Probes). Samples were gated on live cells and data were analysed using FCS Express (De Novo Software, Thornhill, Canada).
DISC isolation J16-Bcl-2 cells were stimulated with 10 Gy IR and 15 h later seeded at 10 8 cells/sample in 30 ml medium in a 15-cm dish. Cell stimulation and DISC isolation was performed essentially as described (Sprick et al., 2002) with some minor modifications. Briefly, cells were cultured at 371C, 5% CO 2 with 1.5 mg ( ¼ 50 ng/ml) FLAG-TRAIL precomplexed to 7.5 mg ( ¼ 250 ng/ml) biotinylated anti-FLAG antibody M2 (Sigma) for the indicated time periods. Next, cells were placed on ice, washed twice with ice-cold PBS and solubilized in Triton X-100 lysis buffer (30 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol and protease inhibitors) for 30 min on ice. Lysates were cleared twice by centrifugation at 13 000 g and resulting protein complexes were precipitated by overnight incubation at 41C with 50 ml streptavidin-conjugated sepharose beads (Zymed, San Francisco, CA, USA). Beads were washed five times with lysis buffer before elution of the protein complexes from the beads with reducing SDS sample buffer.
Cell fractionation
For separation of cytosolic and membrane fractions, cells were washed in PBS and resuspended in 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) pH 7.5, 220 mM mannitol, 68 mM sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM EGTA (ethylene glycol-bis(b-aminoethyl ether)-N,N,N 0 ,N 0 ,-tetraacetic acid), 1 mM dithiothreitol and protease inhibitors (Luo et al., 1998) and allowed to swell on ice for 1 h. Cells were passed through a 26 G needle (10 strokes) and homogenates were centrifuged in a Beckman Airfuge at 100 000 g for 20 min at 41C. Supernatants (cytosol) were harvested and pellets (membranes) were solubilized in Nonidet P-40 lysis buffer (10 mM triethanolamine pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 5 mM EDTA and protease inhibitors) and incubated on ice for 30 min. Next, samples were cleared by centrifugation at 13 000 g for 10 min at 41C.
